Benzinga | Jan 28, 2022 06:22AM EST

SVB Leerink Maintains Market Perform on Alnylam Pharmaceuticals, Raises Price Target to $109

SVB Leerink analyst Mani Foroohar maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $108 to $109.